Nafeh, Frishta
Martignetti, Lucas
Strike, Carol
Kolla, Gillian
Bonn, Matthew
Brunelle, Caroline
Boyd, Jade
Hyshka, Elaine
Morris, Cassidy
Eeuwes, Jolene
Hobbs, Heather
Haywood, Elizabeth
Pauly, Bernadette
Werb, Dan
Karamouzian, Mohammad
Funding for this research was provided by:
Canadian Institutes of Health Research (EV1-174804, EV1-174804)
Article History
Received: 29 July 2024
Accepted: 24 February 2025
First Online: 28 April 2025
Declarations
:
: This study was reviewed and approved by the Unity Health Toronto Research Ethics Board (Project #21–273). Informed consent was obtained from all participants prior to commencing interviews.
: All participants consented for de-identified quotes to be used for scientific manuscripts.
: HH and CM are employed by one of the pilot programs under evaluation. MB grants and personal fees from AbbVie and Gilead Sciences, outside of the submitted work. MB has also worked for the Canadian Association of People Who Use Drugs which receives funds from Health Canada. Other authors have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.